Suchergebnisse - "López, Pío"

PubPharm (5)

1

Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age : A phase 2 randomized, double-blind trial

enthalten in: Human vaccines & immunotherapeutics | 2023

von López, P. | López-Medina, E. | Sáez-Llorens, X. | +6

2

Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age : A phase 2 randomized, double-blind study

enthalten in: Vaccine | 2022

von Vesikari, T. | Saez-Llorens, X. | Blazevic, V. | +8

3

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019 : a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

enthalten in: Lancet (London, England) | 2022

von Bravo, L. | Smolenov, I. | Han, H. | +44

CommentIn: Lancet. 2022 Jan 29;399(10323):415-417. - PMID 35065704

4

Combined administration of MF59-adjuvanted A/H5N1 prepandemic and seasonal influenza vaccines : long-term antibody persistence and robust booster responses 1 year after a one-dose priming schedule

enthalten in: Clinical and vaccine immunology : CVI | 2013

von Lopez, P. | Caicedo, Y. | Sierra, A. | +3

5

Combined, concurrent, and sequential administration of seasonal influenza and MF59-adjuvanted A/H5N1 vaccines : a phase II randomized, controlled trial of immunogenicity and safety in healthy adults

enthalten in: The Journal of infectious diseases | 2011

von Lopez, P. | Caicedo, Y. | Sierra, A. | +3

1
[1]